Senator Mitch McConnell to Introduce Legislation to Legalize Hemp | CashCropToday
0 Shares 211 Views

Senator Mitch McConnell to Introduce Legislation to Legalize Hemp

March 27, 2018
211 Views

Senator Mitch McConnell plans to introduce a new bill which will legalize the use of industrial hemp as an agricultural crop in the United States. McConnell hopes to gain bipartisan support on a new effort to remove hemp from the federal government controlled substance list.

“It’s now time to take the final step and make this a legal crop,” McConnell said.

Industrial hemp is still labeled as a Schedule 1 drug, even though it is the non-psychoactive, industrious cultivar of the cannabis sativa plant. The hemp plant contains 0.3% THC and for some reason still remains federally illegal to grow. Hemp can be manufactured into thousands of  finished goods involved in textiles, bio-composites, bio-fuel, and sustainable building materials.

Senator McConnell was one of the lead supporters of the 2014 Farm Bill which helped implement hemp pilot programs in over 30 states around the country. The Kentucky Senator has backed hemp for the past 4 years and is now the lead sponsor for The Hemp Farming Act of 2018. This new act hopes to continue to establish Kentucky as one of the leading propagators of hemp in the United States, as well as, allow for the commercial revival of a hemp farming industry in the U.S.

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
262 views
Market Watch
262 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
187 views
Global
187 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
185 views
Manufacturing
185 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: